Reaction Details |
| Report a problem with these data |
Target | Oxysterols receptor LXR-beta |
---|
Ligand | BDBM114997 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) |
---|
EC50 | 67622±n/a nM |
---|
Citation | PubChem, PC Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Oxysterols receptor LXR-beta |
---|
Name: | Oxysterols receptor LXR-beta |
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 50978.79 |
Organism: | Homo sapiens (Human) |
Description: | P55055 |
Residue: | 460 |
Sequence: | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDW
VIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGA
RRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQ
SQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKR
SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI
ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR
RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM
LMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
|
|
|
BDBM114997 |
---|
n/a |
---|
Name | BDBM114997 |
Synonyms: | MLS000698346 | N'-(2-methoxybenzylidene)-2-pyridinecarboximidohydrazide | N'-[(Z)-(2-methoxyphenyl)methylideneamino]-2-pyridinecarboximidamide | N'-[(Z)-(2-methoxyphenyl)methylideneamino]pyridine-2-carboximidamide | N'-[(Z)-o-anisylideneamino]picolinamidine | SMR000226343 | cid_5568682 |
Type | Small organic molecule |
Emp. Form. | C14H14N4O |
Mol. Mass. | 254.2872 |
SMILES | COc1ccccc1C=NN=C(N)c1ccccn1 |w:9.10,11.12| |
Structure |
|